Abstract
Selective cytotoxicity is an important goal of specific drug targeting. Toward this end, toxins isolated primarily from higher plants and bacteria have been coupled to monoclonal antibodies (MAbs) and evaluated for their clinical efficacy in cancer, AIDS, and immunological diseases (1,2). Immune responses against murine monoclonal antibodies MAbs (3,4) and antitoxin antibodies have been detected in both animals and humans treated with immunotoxins (ITs) (5–7) and present a major obstacle to the successful application of this technology. Although development of humanized antibodies have alleviated some of these effects (8, and references therein), the toxins themselves remain a problem. Consequently, the identification of human proteins to be used as components of immunoconjugates is highly desirable
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vitetta, E. S., Thorpe, P. E., and Uhr, J. W. (1993) Immunotoxins: magic bullets or misguided missiles. TIPS 14, 148–154.
Brinkmann, U. and Pastan, I. (1994) Immunotoxins against cancer. Biochim. Biophys. Acta 1198, 27–45.
Sawler, D. L., Bartholomew, R. M., Smith, L. M., and Dillman, R. (1985) Human immune response to multiple injections of murine monoclonal IgG. J. Immunol 135, 1530–1535.
Schroff, R. W., Foon, K. A., Beatty, S. M., Oldham, R., and Morgan, A. (1985) Human anti-murine immunoglobulin response in patients receiving monoclonal antibody therapy. Cancer Res 45, 879–885.
Rybak, S. M. and Youle, R. J. (1991) Clinical use of immunotoxins: monoclonal antibodies conjugated to protein toxins. Immunol. Allergy Clin. N. Am 11(2), 359–380.
Harkonen, S., Stoudemire, J., Mischak, R., Spitler, L., Lopez, H., and Scannon, P. (1987) Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxins in rats. Cancer Res 47, 1377–1385.
Hertler, A. (1988) Human response to immunotoxins, in Immunotoxins (Frankel, A. E, ed), Kluwer, Boston, MA, pp. 475–480.
Khazaeli, M. B., Conry, R. M., and LoBuglio, A. F. (1994) Human immune response to monoclonal antibodies. J. Immunother 15, 42–52.
Beintema, J. J., Schuller, C., Irie, M., and Carsana, A. (1988) Molecular evolution of the ribonuclease superfamily. Prog. Biophys. Mol. Biol 51, 165–192.
Gleich, G. J., Loegering, D. A., Bell, M. P., Checkel, J. L., Ackerman, S. J., and McKean, D. J. (1986) Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc. Natl. Acad. Sci. USA 83, 3146–3150.
Strydom, D. J., Fett, J. W., Lobb, R. R., Alderman, E. M., Bethune, J. L., Riordan, J. F., and Vallee, B. L. (1985) Amino acid sequence of human tumor derived angiogenin. Biochemistry 24, 5486–5494.
Kurachi, K., Davie, E. W., Strydom, D. J., Riordan, J. F., and Vallee, B. L. (1985) Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. Biochemistry 24, 5494–5499.
Fett, J. W., Strydom, D. J., Lobb, R. R., Alderman, E. M., Bethune, J. L., Riordan, J. F., and Vallee, B. L. (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24, 5480–5486.
St. Clair, D. K., Rybak, S. M., Riordan, J. F., and Vallee, B. L. (1987) Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of ribosomes. Proc. Natl. Acad. Sci. USA 84, 8330–8334.
Saxena, S. K., Rybak, S. M., Winkler, G., Meade, H. M., McGray, P., Youle, R. J., and Ackerman, E. J. (1991) Comparison of RNases and toxins upon injection into Xenopus oocytes. J. Biol. Chem 266, 21,208–21,214.
Rybak, S. M., Saxena, S. K., Ackerman, E. J., and Youle, R. J. (1991) Cytotoxic potential of RNase and RNase hybrid proteins. J. Biol. Chem 266, 21,202–21, 207.
Newton, D. L., Ilercil, O., Laske, D. W., Oldfield, E., Rybak, S. M., and Youle, R. J. (1992) Cytotoxic ribonuclease chimeras: targeted tumoricidal activity in vitro and in vivo. J. Biol. Chem 267, 19,572–19,578.
Rybak, S. M., Hoogenboom, H. R., Meade, H., Raus, J. C. M., Schwartz, D., and Youle, R. J. (1992) Humanization of immuntoxins. Proc. Natl. Acad. Sci. USA 89, 3165–3169.
Newton, D. L., Nicholls, P. J., Rybak, S. M., and Youle, R. J. (1994) Expression and characterization of recombinant human eosinophil-derived neurotoxin anti-transferrin sFv. J. Biol. Chem 269, 26,739–26,745.
Newton, D. L., Xue, Y., Olsen, K. A., Fett, J. W., and Rybak, S. M. (1996) Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains. Biochemistry 35, 545–553.
Zewe, M., Rybak, S., Dubel, S., Coy, J., Welschof, M., Newton, D., and Little, M. (1997) Cytotoxicity of a human pancreatic RNase A immunotoxin. Immunotechnology 3, 127–136.
Bird, R. E., Hardman, K. D., Jacobson, J. W., Johnson, S., Kaufman, B. M., Lee, S. M., Lee, T., Pope, S. H., Riordan, G. S., and Whitlow, M. (1988) Single-chain antigen-binding proteins. Science 242, 423–426.
Huston, J. S., Mudgett-Hunter, M., Tai, M. S., McCartny, J., Warren, F., Haber, E., and Oppermann, H. (1991) Protein engineering of single-chain Fv analogs and fusion proteins. Methods Enzymol 203, 46–88.
Horten, R. M., Cai, Z., Ho, S. N., and Pease, L. R. (1990) Gene splicing by overlay extension: tailor made genes using the polymerase chain reaction. BioTechniques 8, 528–535.
Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. (1990) Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 185, 60–89.
Horton, R. (1993) In vitro recombination and mutagenesis of DNA; SOEing together tailor-made genes, in Methods in Molecular Biology, vol. 15: PCR Protocols: Current Methods and Applications (White, B. A., ed.), Humana, Totowa, NJ, pp. 251–261.
Wehrli, W., Knusel, F., Schmid, K., and Staehelin, M. (1968) Interaction of rifa-mycin with bacterial RNA polymerase. Proc. Natl. Acad. Sci. USA 61, 667–673.
Worrall, D. M. (1994) Extraction of recombinant protein from bacteria, in Methods in Molecular Biology, vol. 59: cDNA Library Protocols (Cowell, I. G. and Austin, C. A., eds.), Totowa, NJ, pp. 31–37.
Buchner, J., Pastan, I., and Brinkmann, U. (1992) A method for increasing the yield of properly folded recombinant fusion proteins: single chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem 205, 263–270.
Brinkmann, U., Buchner, J., and Pastan, I. (1992) Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections. Proc. Natl. Acad. Sci. USA 89, 3075–3079.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Newton, D.L., Rybak, S.M. (2000). Preparation of Recombinant RNase Single-Chain Antibody Fusion Proteins. In: Francis, G.E., Delgado, C. (eds) Drug Targeting. Methods in Molecular Medicine™, vol 25. Humana Press. https://doi.org/10.1385/1-59259-075-6:77
Download citation
DOI: https://doi.org/10.1385/1-59259-075-6:77
Publisher Name: Humana Press
Print ISBN: 978-0-89603-531-7
Online ISBN: 978-1-59259-075-9
eBook Packages: Springer Protocols